CAPASSO, ANTONELLA
 Distribuzione geografica
Continente #
AS - Asia 26
NA - Nord America 25
EU - Europa 24
OC - Oceania 1
Totale 76
Nazione #
US - Stati Uniti d'America 24
CN - Cina 19
IT - Italia 6
SG - Singapore 6
RU - Federazione Russa 5
SE - Svezia 4
FI - Finlandia 2
FR - Francia 2
GB - Regno Unito 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CA - Canada 1
IN - India 1
LT - Lituania 1
Totale 76
Città #
Shanghai 9
Ashburn 6
Boardman 6
Moscow 4
Dallas 3
Singapore 3
Lappeenranta 2
Seattle 2
Zhengzhou 2
Alessandria 1
Brussels 1
Buffalo 1
Guangzhou 1
Handan 1
Hangzhou 1
Jiaxing 1
Ottawa 1
Pune 1
Rome 1
Shenzhen 1
Washington 1
Totale 49
Nome #
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 22
MINIMAL RESIDUAL DISEASE-DRIVEN TREATMENT INTENSIFICATION WITH SEQUENTIAL ADDITION OF IBRUTINIB TO VENETOCLAX IN R/R CLL 17
CLL-461 Humoral Response to COVID-19 Vaccine: A Challenge in CLL 15
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL 14
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL 13
Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL 9
Totale 90
Categoria #
all - tutte 963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 3 2 0 1 1 0 0 3
2023/202445 4 0 1 5 0 6 1 6 0 3 2 17
2024/202535 9 4 4 0 10 8 0 0 0 0 0 0
Totale 90